EBR Systems, Inc. (ASX: EBR) has received FDA approval of the WiSE® System, which marks a significant leap forward in the treatment of heart failure. Unlike conventional CRT, the WiSE System is the ...

Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.

EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has ...

The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...

Does walking count as exercise? Yes, walking is exercise, and experts across physical and mental health disciplines agree.

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle ...

Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardiaSOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc.

Adagio Medical shares are trading higher by 142% during Thursday's session. The FDA granted Breakthrough Device Designation for the vCLAS cryoablation system.

Systems announced the US commercial release of its Ventrax Delivery System. The new delivery system is Merit’s latest ...

Corporation will be exhibiting at the MedAxiom CV Transforum Spring’25 Conference being held at the Renaissance Orlando at SeaWorld ...